IISc signs MoU with Wipro GE Healthcare to advance medtech innovation from India

23 January 2024 | News

Aimed at increasing industry-academia knowledge sharing in emerging technology areas

Wipro GE Healthcare has signed a Memorandum of Understanding (MoU) with the Indian Institute of Science (IISc), Bengaluru, for a pioneering alliance to advance healthcare innovation, research, and technology development in India.

This collaboration aims to take a comprehensive approach in solving the care gap by addressing the full lifecycle that includes co-developing solutions, validating the technologies, and manufacturing them locally to bring them to the market.

With the impending commencement of the Bagchi-Parthasarathy Hospital & IISc Medical School, this strategic collaboration will enable translation of technologies from bench to bedside. 

The collaboration will entail co-development initiatives in the areas of basic and applied science, systems engineering, product & software development, consultancy, joint IP & publications, academic studies, internships, fellowships, and training. IISc and GE HealthCare will constitute a joint working committee, comprising representatives from both sides, for research around product and solution development.

Govindan Rangarajan, Director, Indian Institute of Science (IISc), said, “The collaboration will emphasise combining science and engineering with translational & clinical research to epitomise “bench-to-bedside” innovation. GE HealthCare is the right partner for us in this initiative, given their leadership and strong footprint in India for R&D and manufacturing."

Chaitanya Sarawate, Managing Director, Wipro GE Healthcare and President & CEO, GE HealthCare South Asia, said, “This is a strategic collaboration that combines the strengths, capabilities, and local infrastructure of both entities. Our aim together is to invest in technologies of the future that can revolutionize the care paradigm – with more precise, connected, and compassionate care to patients in India and worldwide.”


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account